Intellia Therapeutics, Inc.
Polynucleotides, Compositions, and Methods for Genome Editing
Last updated:
Abstract:
Compositions and methods for gene editing. In some embodiments, a polynucleotide encoding Cas9 is provided that can provide one or more of improved editing efficiency, reduced immunogenicity, or other benefits.
Status:
Application
Type:
Utility
Filling date:
24 Mar 2020
Issue date:
12 Nov 2020